Roivant

We founded Roivant in 2014 to quickly deliver innovative medicines and technologies to patients, improving their health. We do this by building “Vants”—our nimble, entrepreneurial biotech and healthcare technology companies.

This model allows us to source talent, align incentives, and deploy technology across discovery, development, and commercialization efficiently. Our family of companies targets various diseases, including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where R&D investment is disproportionately low compared to societal medical needs.

Besides biopharmaceutical Vants, we also build technology-focused Vants to improve how medicines are developed and sold. Since 2019, our Vants have conducted 12 positive Phase 3 trials and achieved 8 FDA approvals. In 2022, we launched VTAMA® (tapinarof) cream, 1%, for the topical treatment of plaque psoriasis in adults. Organon acquired Dermavant, one of our Vants, in 2024.

Our mission is to improve health by quickly delivering innovative medicines and technologies to patients. We aim to accelerate the development and commercialization of important medicines to improve patient lives.

Our values include an open, diverse, and inclusive culture. We embrace diversity and ensure every employee is supported in reaching their full potential.

We commit to attracting and retaining top talent, generating new ideas, and promoting a collaborative culture where all employees feel valued, respected, and empowered to create value for patients.

The company employs 201-500 individuals, including dedicated scientists, development experts, investors, entrepreneurs, and engineers.

Roivant’s culture is rooted in innovation, encouraging non-linear career trajectories and diverse career paths within its family of companies. Employees are empowered to be architects of their own careers.

The company has built a diverse leadership team, board of directors, and employee base, striving for an open, diverse, and inclusive environment. Roivant hires motivated people with diverse backgrounds, identities, experiences, and skillsets. Employees can contribute to teams expanding established treatments and technology or to start-ups exploring new ideas.

Clinical and corporate teams are located in New York City and Basel, Switzerland. Some roles offer hybrid work options.

We provide benefits to support employee health and well-being. These include medical, dental, and vision benefits, a 401(k) plan with company match, unlimited PTO, and generous parental and family leave.

We also offer work-from-home and commuter benefits, as well as employee resource groups. Compensation packages may include discretionary bonuses, equity, and company-sponsored benefits.